Incidence of hospital admissions in bioimpedance-guided fluid management among maintenance hemodialysis patients-Results of a randomized controlled trial

被引:3
|
作者
Stigger, Kaiane [1 ]
Ribeiro, Larissa Ribas [1 ,2 ]
Cordeiro, Fernanda Moraez [1 ,2 ]
Boehlke, Maristela [1 ,2 ]
机构
[1] Univ Catolica Pelotas, Postgrad Program Hlth & Behav, Pelotas, Brazil
[2] Univ Catolica Pelotas, Univ Hosp Sao Francisco Paula, Dialysis & Transplantat Unit, Pelotas, Brazil
关键词
bioimpedance spectroscopy; BIS; fluid status; hemodialysis; overhydration; BLOOD-PRESSURE; DRY-WEIGHT; SPECTROSCOPY; OVERLOAD; MORTALITY; ULTRAFILTRATION; HYDRATION;
D O I
10.1111/hdi.13076
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Hemodialysis is life-sustaining in kidney failure. However, proper regulation of body fluids depends on an accurate estimate of target weight. This trial aims to compare clinical endpoints between target weight estimation guided by bioimpedance spectroscopy and usual care in hemodialysis patients. Methods: This is an open-label, parallel-group, controlled trial that randomized, through a table of random numbers, adult patients on maintenance hemodialysis to target weight estimation based on monthly clinical evaluation alone or added to evaluation by bioimpedance twice a year. The primary outcome was survival, and the secondary outcomes were the rate of hospital admissions, change in blood pressure (BP), and antihypertensive drugs load. Participants were followed for 2 years. Survival analysis was performed using Kaplan-Meier estimator and Log-rank test, and hospital admissions were analyzed by the incidence-rate ratio. Findings: One hundred and ten patients were randomized to the usual care (52) or bioimpedance (58) groups, with a mean age of 57.4 (15.4) years, 64 (58%) males. There was no difference between the groups at baseline. Survival was not significantly different between groups (log-rank test p = 0.68), but the trial was underpowered for this outcome. There was also no difference between the groups in the change in systolic or diastolic BP or in the number of antihypertensive drugs being used. The incidence rate of hospital admissions was 3.1 and 2.1 per person-year in usual care and bioimpedance groups, respectively, with a time-adjusted incidence rate ratio of 1.48 (95% CI: 1.20-1.82, p = 0.0001) and attributable fraction of risk among exposed individuals of 0.32 (95% CI: 0.17-0.45). Discussion: The inclusion of bioimpedance data to guide the estimation of target weight in hemodialysis patients had no detectable impact on survival or BP control, but significantly reduced the incidence rate of hospital admissions.
引用
收藏
页码:318 / 325
页数:8
相关论文
共 50 条
  • [41] OPTIMIZATION OF FLARE MANAGEMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS OF A RANDOMIZED CONTROLLED TRIAL
    Myasoedova, Elena
    Crowson, Cynthia S.
    Giblon, Rachel
    Schaffer, Daniel
    Wright, Kerry
    Matteson, Eric
    Davis, John
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 236 - 237
  • [42] Optimization of flare management in patients with rheumatoid arthritis: results of a randomized controlled trial
    Elena Myasoedova
    Cynthia S. Crowson
    Rachel E. Giblon
    Kathleen McCarthy-Fruin
    Daniel E. Schaffer
    Kerry Wright
    Eric L. Matteson
    John M. Davis
    Clinical Rheumatology, 2019, 38 : 3025 - 3032
  • [43] Therapy Software for Personalized Anemia Management in Hemodialysis Patients: Description of the Population in a Randomized Controlled Trial
    Fuentes, Lemuel Rivera
    Joerg, David J.
    Fuertinger, Doris H.
    Wang, Lin-Chun
    Patel, Amrish U.
    Ye, Xiaoling
    Thijssen, Stephan
    Kotanko, Peter
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 905 - 906
  • [44] Maintenance Intravenous Iron in Hemodialysis Patients to Minimize Erythropoietin Doses: A Double-Blinded, Randomized Controlled Trial
    Tantiyavarong, Pichaya
    Anumas, Suthiya A.
    Chatkrailert, Aphichat
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 237 - 237
  • [45] The impact of intradialytic elastic band exercise on physical and cognitive abilities in patients on maintenance hemodialysis: a randomized controlled trial
    Feng, Xianxuan
    Sun, Jingwen
    Wang, Zihan
    Zhang, Nina
    Liu, Yumei
    Wang, Zhenhong
    Wang, Niansong
    Jian, Guihua
    Cheng, Dongsheng
    Sheng, Xiaohua
    Ma, Yanhong
    RENAL FAILURE, 2025, 47 (01)
  • [46] Effect of Maintenance Intravenous Iron Treatment on Erythropoietin Dose in Chronic Hemodialysis Patients: A Multicenter Randomized Controlled Trial
    Susantitaphong, Paweena
    Siribumrungwong, Monchai
    Takkavatakarn, Kullaya
    Chongthanakorn, Kamonrat
    Lieusuwan, Songkiat
    Katavetin, Pisut
    Tiranathanagul, Khajohn
    Lekhyananda, Sookruetai
    Tungsanga, Kriang
    Vanichakarn, Supat
    Eiam-Ong, Somchai
    Praditpornsilpa, Kearkiat
    CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2020, 7
  • [47] Esophageal Doppler-guided fluid management decreases blood lactate levels in multiple-trauma patients:: a randomized controlled trial
    Chytra, Ivan
    Pradl, Richard
    Bosman, Roman
    Pelnar, Petr
    Kasal, Eduard
    Zidkova, Alexandra
    CRITICAL CARE, 2007, 11 (01):
  • [48] A randomized controlled trial of long term effect of BCM guided fluid management in MHD patients (BOCOMO study): rationales and study design
    Li Liu
    Gang Long
    Jianwei Ren
    Jijun Li
    Jinsheng Xu
    Jinghong Lei
    Mao Li
    Moyan Qiu
    Ping Yuan
    Weiming Sun
    Shan Lin
    Wenjun Liu
    Yi Sun
    Yingchun Ma
    Yonghui Mao
    Yulan Shen
    Li Zuo
    BMC Nephrology, 13
  • [49] Effects of Spironolactone on Arrhythmias in Hemodialysis Patients: Secondary Results of the SPin-D Randomized Controlled Trial
    Mc Causland, Finnian R.
    Hsu, Jesse Y.
    Himmelfarb, Jonathan
    Ikizler, Talat Alp
    Raj, Dominic S.
    Mehrotra, Rajnish
    Waikar, Sushrut S.
    Kimmel, Paul L.
    Kliger, Alan S.
    Dember, Laura M.
    Charytan, David M.
    KIDNEY360, 2023, 4 (04): : E486 - E495
  • [50] A randomized controlled trial of long term effect of BCM guided fluid management in MHD patients (BOCOMO study): rationales and study design
    Liu, Li
    Long, Gang
    Ren, Jianwei
    Li, Jijun
    Xu, Jinsheng
    Lei, Jinghong
    Li, Mao
    Qiu, Moyan
    Yuan, Ping
    Sun, Weiming
    Lin, Shan
    Liu, Wenjun
    Sun, Yi
    Ma, Yingchun
    Mao, Yonghui
    Shen, Yulan
    Zuo, Li
    BMC NEPHROLOGY, 2012, 13